Literature DB >> 2455263

Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.

O Shohat1, M Greenberg, D Reisman, M Oren, V Rotter.   

Abstract

p53 is an oncogene product which has been shown to be directly involved in malignant transformation. Furthermore, it has been proposed that this protein plays an essential role in the control of cell proliferation. In the present study, we investigated the involvement of p53 in growth regulation of cells by employing anti-sense RNA methodology to inhibit p53 expression. Transfection with p53-specific constructs spanning the entire mRNA molecule or the 5' region of the gene led to reduced p53 protein synthesis. Clones derived from such transfected cells exhibited a slower rate of DNA synthesis, as assayed by incorporation of [3H]thymidine. In most cases, transfection of plasmids encoding anti-sense RNA eventually brought about the complete cessation of cell proliferation. No such effects were observed in L12 cells, which do not synthesize p53 and therefore do not depend on p53 expression for their growth, thus excluding the possibility of a non-specific toxic effect exerted by the anti-sense p53 RNA. These findings support the notion that p53 is essential for continuous cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2455263

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation.

Authors:  K Fukasawa; G Sakoulas; R E Pollack; S Chen
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways.

Authors:  U K Messmer; B Brüne
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

4.  Oligomerization of oncoprotein p53.

Authors:  S Kraiss; A Quaiser; M Oren; M Montenarh
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Genetic basis for p53 overexpression in human breast cancer.

Authors:  A M Davidoff; P A Humphrey; J D Iglehart; J R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

6.  Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation.

Authors:  S J van den Heuvel; T van Laar; I The; A J van der Eb
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Extrachromosomal, homologous expression of trypanothione reductase and its complementary mRNA in Trypanosoma cruzi.

Authors:  J Tovar; A H Fairlamb
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

8.  Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.

Authors:  M M Lotz; C W Andrews; C A Korzelius; E C Lee; G D Steele; A Clarke; A M Mercurio
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.

Authors:  T Crook; C Fisher; K H Vousden
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  The p53 tumor suppressor gene. A preliminary clinical study in breast cancer patients.

Authors:  G Micelli; A Donadeo; M Quaranta
Journal:  Cell Biophys       Date:  1992 Aug-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.